Brookdale Senior Living
- Market cap
- 2.57B
- P/E (TTM)i
- -18.25
- P/Bi
- -89.01
- EPSi
- -1.12
- Div yieldi
- 0.00%
- 52W posi
- 30%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Medical Care Facilities
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Brookdale Senior Living (BKD) | 2.57B | -18.25 | -89.01 | 0.00% |
| HCA Healthcare (HCA) | 95.08B | 14.73 | -14.32 | 0.68% |
| Tenet Healthcare (THC) | 20.92B | 10.04 | 4.49 | 0.00% |
| Encompass Health (EHC) | 12.08B | 19.95 | 4.65 | 0.62% |
| DaVita (DVA) | 11.28B | 14.57 | -14.74 | 0.00% |
| Fresenius Medical Care (FMS) | 11.01B | 11.14 | 0.78 | 4.13% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 8.2% above Morningstar's fair value estimate.
Fair value
Brookdale Senior Living Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 6% premium over our quantitative fair value estimate of $9.89 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.
The firm's lack of profitability weakens our estimated fair value. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's earnings yield of -1.3% ranks in the bottom 30% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which contributes to our view that shares are expensive.
The company's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of -1.1%, for example, ranks in the bottom 10% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which further promotes our unfavorable price/fair value ratio.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.
Economic moat
The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-08 06:19:20 · For reference only, not investment advice and not tailored to your situation.